New research from a team of Cornell collaborators points to a possible target for antiviral treatment for COVID-19. Their review paper, “Coronavirus Membrane Fusion Mechanism Offers a Potential Target for Antiviral Development,” published April 6 in Antiviral Research. The multidisciplinary group was led by Susan Daniel, associate professor of chemical and biomolecular engineering, and Gary Whittaker, professor of virology at the College of Veterinary Medicine.
A biomanufacturing company spun out of Cornell research is seeking to rapidly translate an antibody therapy against COVID-19 by using cell-free biotechnology based on glycoengineered bacteria. And it could scale up the production 10 times faster than conventional methods. The company, SwiftScale Biologics, was co-founded by Center member Matt DeLisa.
Brianne Barker joins Immune, co-hosted by Cynthia Leifer, to discuss the immune response to infection with SARS-CoV-2, including immune response, pathogenesis, immunopathology and more. Hosts: Vincent Racaniello, Stephanie Langel, and Cynthia Leifer Guest: Brianne Barker
As hospitals across the country try to manage a surge in coronavirus patients while also facing a global shortage in the protective gear needed to treat them, the Cornell community has banded together to donate crucial medical supplies to local health care providers.
The Cornell Center for Immunology is thrilled to share the individuals and projects that have been selected to receive Core Facilities Seed Funds.
Everyone is working together, pitching in to find solutions while suspending research and closing down laboratories. Find out what is going on and how researchers plan to be productive remotely.
While many researchers have faced a temporary work stoppage, Gary Whittaker, is leading a working group of core laboratories trying to better understand COVID-19, with the hope of future treatment and containment.
The Department of Microbiology and Immunology in the College of Veterinary Medicine celebrated this year’s recipients of the Biocytogen Best Research Paper Awards on March 5. In a brief ceremony, department chair Dr. Ted Clark recognized fourth-year Ph.D. student Cybelle Tabilas for her first-place paper, as well as recent graduate Angela Yan, Ph.D. ’19, for the runner-up prize.
Urinary tract infections (UTIs) in kidney transplant patients may be caused by bacteria that originate in the digestive tract, according to investigators at Weill Cornell Medicine, Cornell University, and NewYork-Presbyterian.
Dr. David Russell, the William Kaplan Professor of Infection Biology in the Department of Microbiology and Immunology in the Cornell College of Veterinary Medicine, has used a cutting-edge method for illuminating the interaction between the bacteria that cause tuberculosis and two different kinds of host cells.
